US2013121972A1PendingUtilityA1
Native wharton's jelly stem cells and their purification
Individually held — no corporate assignee on recordPriority: Jun 1, 2010Filed: Jun 1, 2011Published: May 16, 2013
Est. expiryJun 1, 2030(~3.8 yrs left)· nominal 20-yr term from priority
Inventors:Rouzbeh R. Taghizadeh
C12N 5/06A61L 27/3834C12N 2500/84C12N 5/0662C12N 5/0605C12N 5/0668C12N 5/0602C12N 5/0037C12N 5/00C12N 2502/025A61K 35/51
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Noncultured Wharton's Jelly stem cells and methods of their purification, storage and use are provided.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method of purifying noncultured Wharton's Jelly stem cells, the method comprising separating noncultured Wharton's Jelly stem cells from a digested tissue comprising Wharton's Jelly.
2 . The method of claim 1 , further comprising digesting a tissue comprising Wharton's Jelly.
3 - 5 . (canceled)
6 . A method according to claim 2 , wherein the tissue is digested by mechanically increasing the surface area of the tissue.
7 . The method of claim 6 , comprising cutting the tissue.
8 . The method of claim 6 , comprising mincing the tissue.
9 . (canceled)
10 . A method according to claim 2 , further comprising separating digested and undigested tissue.
11 . The method of claim 10 , comprising sedimenting the undigested tissue.
12 . The method of claim 11 , wherein centrifugation is used for sedimenting the undigested tissue.
13 . The method of claim 10 , comprising filtering the digested tissue.
14 . The method of claim 13 , wherein the noncultured Wharton's Jelly stem cells are separated from the filtrate.
15 . A method according to claim 10 , further comprising washing or diluting the digested tissue before separating it from the undigested tissue.
16 . A method of purifying cultured and noncultured Wharton's Jelly stem cells, the method comprising:
purifying noncultured Wharton's Jelly stem cells according to claim 10 ; and culturing mesenchymal stem cells from the undigested tissue.
17 . The method of claim 16 , wherein the mesenchymal stem cells are cultured in digested Wharton's Jelly.
18 . Purified, noncultured Wharton's Jelly stem cells substantially free of semi-solid Wharton's Jelly.
19 . Purified, noncultured Wharton's Jelly stem cells at a temperature below −20° C.
20 . Wharton's Jelly stem cells according to claim 18 , wherein the cells have reduced CD73 and reduced CD105 levels compared to cultured mesenchymal stem cells.
21 . Wharton's Jelly stem cells according to claim 18 , wherein the Wharton's Jelly stem cells are maintained in a sterile solution.
22 . (canceled)
23 . A method of treating a subject, the method comprising administering to the subject Wharton's Jelly stem cells according to claim 18 .
24 . (canceled)
25 . A homogeneous solution comprising Wharton's Jelly.
26 - 28 . (canceled)
29 . A method of maintaining a cell comprising mixing the cell in the solution of claim 25 .
30 - 32 . (canceled)Join the waitlist — get patent alerts
Track US2013121972A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.